Expedited Program for Serious Conditions-Accelerated Approval of Drugs and Biologics; Draft Guidance for Industry; Extension of Comment Period
Published Date: 1/17/2025
Notice
Summary
The FDA is giving drug makers and the public more time to share their thoughts on new rules that speed up approval for important medicines treating serious illnesses. This extension means comments are now due by March 6, 2025, helping ensure everyone’s voice is heard before final decisions. If you’re involved in developing or using these drugs, this extra time could impact how quickly new treatments reach patients.
Free Policy Watch
New rules are filed every week. Most people never see them.
Pick a topic. PRIA watches every federal rule and tells you when one hits your household.
Pick a topic to get started
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in